» Articles » PMID: 30776558

Click Chemistry Based Multicomponent Approach in the Synthesis of Spirochromenocarbazole Tethered 1,2,3-triazoles As Potential Anticancer Agents

Overview
Journal Bioorg Chem
Publisher Elsevier
Specialties Biochemistry
Chemistry
Date 2019 Feb 19
PMID 30776558
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A series of spirochromenocarbazole tethered 1,2,3-triazoles were synthesized via click chemistry based one-pot, five component reaction between N-propargyl isatins, malononitrile, 4-hydroxycarbazole, aralkyl halides and sodium azide using cellulose supported CuI nanoparticles (Cell-CuI NPs) as the heterogeneous catalyst. Antiproliferative activity of all the synthesized compounds was investigated against panel of cancer cell lines such as MCF-7, MDA-MB-231, HeLa, PANC-1, A-549, and THP-1. Many of the synthesized compounds exhibited good anti-proliferative activity against breast (MCF-7 and MDA-MB-231) and cervical (HeLa) cancer cells with IC values less than 10 μM. In case of MCF-7 cells, among the nine compounds that showed good anti-proliferative activity, compounds 6f and 6j were found to be highly potent (IC = 2.13 μM and 4.80 μM, respectively). In case of MDA-MB-231, three compounds (6k, 6j and 6s) showed antiproliferative activity amongst which 6k was the most potent one (IC = 3.78 μM). On the other hand, in cervical cancer HeLa cells, compounds 6b, 6g, 6s and 6u showed excellent antiproliferative activity (IC = 4.05, 3.54, 3.83, 3.35 μM, respectively). All the compounds were found to be nontoxic to the human umbilical vein endothelial cells (HUVECs). AO and EtBr staining and fluorescence microscopy studies of the active compounds (IC < 5 μM) suggested that these compounds induce cell death by apoptosis.

Citing Articles

Click Chemistry: an overview and recent updates in the medicinal attributes of click-derived heterocycles.

Bishnoi P, Saroha B, Kumar S, Kumar G, Bhardwaj A, Kumari M Mol Divers. 2025; .

PMID: 39918713 DOI: 10.1007/s11030-025-11110-z.


Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy.

Nafie M, Ali M, Alwehaibi M, Alayyaf A, Al-Muhanna M, Almuqati N RSC Adv. 2025; 15(1):58-74.

PMID: 39763621 PMC: 11701428. DOI: 10.1039/d4ra05966b.


Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights.

Hassan S, Farid A, Panda S, Bekheit M, Dinkins H, Fayad W Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065774 PMC: 11280311. DOI: 10.3390/ph17070922.


Synthesis and biological evaluation of 4-(1-1,2,4-triazol-1-yl)benzoic acid hybrids as anticancer agents.

Abuelizz H, Awad H, Marzouk M, Nasr F, Alqahtani A, Bakheit A RSC Adv. 2022; 9(33):19065-19074.

PMID: 35516906 PMC: 9064907. DOI: 10.1039/c9ra03151k.


Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole.

Deng P, Sun G, Zhao J, Yao K, Yuan M, Peng L Front Pharmacol. 2022; 12:793905.

PMID: 35111061 PMC: 8802806. DOI: 10.3389/fphar.2021.793905.